Search

Search Constraints

You searched for: Author/Creator Fast, Patricia E.

Search Results

1. A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus–Seronegative Men. (11th August 2016)

2. Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines. Issue 49 (17th November 2020)

3. Comparison of HIV incidence estimated in clinical trial and observational cohort settings in a high risk fishing population in Uganda: Implications for sample size estimates. Issue 15 (4th April 2016)

4. Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa. (28th November 2017)

5. RVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment. (11th April 2019)

8. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines. Issue 39 (3rd September 2020)

9. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines. Issue 34 (22nd July 2020)

10. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines. Issue 35 (31st July 2020)